CLINICAL RESEARCH ORGANIZATION MASTER SERVICES AGREEMENTIndividual Project Agreement • September 28th, 2018 • Arog Pharmaceuticals, Inc. • Pharmaceutical preparations • Texas
This Clinical Research Organization Master Services Agreement (“Agreement”), is effective June 12, 2018 (the “Effective Date”), by and between AROG PHARMACEUTICALS, INC., a Delaware corporation, having a principal place of business at 5420 LBJ Freeway, Suite 410, Dallas TX 75240 (“Sponsor”), and DAVA ONCOLOGY, LP D/B/A DAVA CRO SERVICES, having a principal place of business at or address at 5420 LBJ Freeway, Suite 410, Dallas, TX 75240 (“CRO”). Sponsor and CRO may be referred to herein individually as a “Party” or, collectively, as the “Parties”.
LICENSE AGREEMENTLicense Agreement • September 28th, 2018 • Arog Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This License Agreement (the “Agreement”) is entered into and made effective as of January 5, 2015 (“Effective Date”) by and between Arog Pharmaceuticals Inc., a Delaware corporation having a place of business at 5420 LBJ Freeway, Suite 410, Dallas, Texas 75240 (“Company”) and Videra Pharmaceuticals, LLC, a Delaware limited liability company having a place of business at 5420 LBJ Freeway, Suite 410, Dallas, Texas 75240 (“Licensee”). Licensee and Company are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
Consultant Services AgreementConsultant Services Agreement • September 28th, 2018 • Arog Pharmaceuticals, Inc. • Pharmaceutical preparations • Texas
This Agreement (this “Agreement”), effective as January 1, 2014 (the “Effective Date”) sets forth the terms and conditions whereby Vinay Jain, M.D. (“Consultant”) will provide certain services for AROG Pharmaceuticals , Inc. (“AROG”). Consultant and AROG are referred each individually referred to herein as a “Party” and collectively as the “Parties.”
First Amendment to the April 11, 2018 Loan Agreement between AROG Pharmaceuticals, Inc. and Jain Investments, LLCFirst Amendment • September 28th, 2018 • Arog Pharmaceuticals, Inc. • Pharmaceutical preparations
This First Amendment (“Amendment”), dated May 30, 2018, is made by and between AROG Pharmaceuticals, Inc. (the “Borrower”), with a place of business at 5420 LBJ Freeway, Suite. 410, Dallas, Texas 75240, and Jain Investments, LLC (the “Lender”), with a place of business at 5420 LBJ Freeway, Suite 410, Dallas, Texas 75240.
LOAN AGREEMENTLoan Agreement • September 28th, 2018 • Arog Pharmaceuticals, Inc. • Pharmaceutical preparations • Texas
THIS LOAN AGREEMENT (this “Loan Agreement”) dated effective as of September 8, 2017 (the “Effective Date”) is made and executed by and between Jain Investments, LLC, a Texas limited liability company (the “Lender”) and Arog Pharmaceuticals, Inc., a Delaware corporation (the “Borrower”).
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • September 28th, 2018 • Arog Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Asset Purchase Agreement (this “Agreement”) is made and entered into effective as of January 5, 2015 (the “Effective Date”), by and between Arog Pharmaceuticals, Inc., a Delaware corporation (“Seller”), and Videra Pharmaceuticals, LLC a Delaware limited liability company (“Buyer”). Seller and Buyer are sometimes referred to herein as the “Parties,” and each, a “Party.”
